ISOCAINE (MEPIVACAINE HCL) INJECTION 3%
Product details
Registration number: SIN14649P
Classification: Prescription Only
Active ingredients: Mepivacaine HCl
Strength: 30 mg/mL
Dosage form: INJECTION
Route: SUBCUTANEOUS
Registrant: N.K. LUCK (S) PTE LTD
ATC code: N01BB03
HSA approval date: 24 October 2014
Manufacturer(s): Novocol Pharmaceutical of Canada, Inc.
Manufacturing country/countries: CANADA
What are the HSA registration number and classification for ISOCAINE (MEPIVACAINE HCL) INJECTION 3%?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN14649P
Classification: Prescription Only
What active ingredients and strength are recorded for ISOCAINE (MEPIVACAINE HCL) INJECTION 3%?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Mepivacaine HCl
Strength: 30 mg/mL
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for ISOCAINE (MEPIVACAINE HCL) INJECTION 3%?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION
Route: SUBCUTANEOUS
Who is the recorded registrant for ISOCAINE (MEPIVACAINE HCL) INJECTION 3%?
According to the HSA dataset updated 7 August 2026:
Registrant: N.K. LUCK (S) PTE LTD
Which manufacturers and countries are listed for ISOCAINE (MEPIVACAINE HCL) INJECTION 3%?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Novocol Pharmaceutical of Canada, Inc.
Manufacturing country/countries: CANADA
Where can I look up ISOCAINE (MEPIVACAINE HCL) INJECTION 3% in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN14649P or the exact product name ISOCAINE (MEPIVACAINE HCL) INJECTION 3%. The general register link does not preselect this product.
What are the source dates for this ISOCAINE (MEPIVACAINE HCL) INJECTION 3% record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this ISOCAINE (MEPIVACAINE HCL) INJECTION 3% record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN14649P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)